Insurers across the nation are arguing that they do not have to defend policy holders against opioid-related claims while lawsuits alleging that drug companies, distributors, and pharmacies mislead consumers and health care providers as to the addiction risks of opioids continue to pile up. No concrete legislation is in place regarding these cases, but both policy holders and insurers are waiting to see how the laws develop.
